Logo image of ALWIT.PA

WITBE.NET (ALWIT.PA) Stock Fundamental Analysis

Europe - EPA:ALWIT - FR0013143872 - Common Stock

1.7 EUR
-0.03 (-1.45%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALWIT gets a fundamental rating of 3 out of 10. We evaluated ALWIT against 76 industry peers in the IT Services industry. The financial health of ALWIT is average, but there are quite some concerns on its profitability. ALWIT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALWIT has reported negative net income.
ALWIT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALWIT reported negative net income in multiple years.
Of the past 5 years ALWIT 4 years had a positive operating cash flow.
ALWIT.PA Yearly Net Income VS EBIT VS OCF VS FCFALWIT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

The Return On Assets of ALWIT (-5.53%) is worse than 77.46% of its industry peers.
Looking at the Return On Equity, with a value of -22.19%, ALWIT is doing worse than 76.06% of the companies in the same industry.
Industry RankSector Rank
ROA -5.53%
ROE -22.19%
ROIC N/A
ROA(3y)-3.11%
ROA(5y)-3.02%
ROE(3y)-11.7%
ROE(5y)-16.08%
ROIC(3y)N/A
ROIC(5y)N/A
ALWIT.PA Yearly ROA, ROE, ROICALWIT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With an excellent Gross Margin value of 101.76%, ALWIT belongs to the best of the industry, outperforming 97.18% of the companies in the same industry.
ALWIT's Gross Margin has improved in the last couple of years.
ALWIT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 101.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y3.08%
ALWIT.PA Yearly Profit, Operating, Gross MarginsALWIT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80 100

4

2. Health

2.1 Basic Checks

ALWIT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALWIT remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALWIT has been increased compared to 5 years ago.
ALWIT has a better debt/assets ratio than last year.
ALWIT.PA Yearly Shares OutstandingALWIT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
ALWIT.PA Yearly Total Debt VS Total AssetsALWIT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

ALWIT has an Altman-Z score of 0.98. This is a bad value and indicates that ALWIT is not financially healthy and even has some risk of bankruptcy.
ALWIT's Altman-Z score of 0.98 is on the low side compared to the rest of the industry. ALWIT is outperformed by 83.10% of its industry peers.
ALWIT has a debt to FCF ratio of 2.51. This is a good value and a sign of high solvency as ALWIT would need 2.51 years to pay back of all of its debts.
ALWIT's Debt to FCF ratio of 2.51 is fine compared to the rest of the industry. ALWIT outperforms 66.20% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that ALWIT is somewhat dependend on debt financing.
ALWIT has a Debt to Equity ratio of 0.55. This is comparable to the rest of the industry: ALWIT outperforms 40.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.51
Altman-Z 0.98
ROIC/WACCN/A
WACC6.27%
ALWIT.PA Yearly LT Debt VS Equity VS FCFALWIT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M

2.3 Liquidity

ALWIT has a Current Ratio of 1.49. This is a normal value and indicates that ALWIT is financially healthy and should not expect problems in meeting its short term obligations.
ALWIT has a better Current ratio (1.49) than 67.61% of its industry peers.
ALWIT has a Quick Ratio of 1.38. This is a normal value and indicates that ALWIT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.38, ALWIT is doing good in the industry, outperforming 66.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.38
ALWIT.PA Yearly Current Assets VS Current LiabilitesALWIT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

3. Growth

3.1 Past

ALWIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.73%, which is quite impressive.
The Revenue has decreased by -4.14% in the past year.
ALWIT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.13% yearly.
EPS 1Y (TTM)25.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.97%
Revenue 1Y (TTM)-4.14%
Revenue growth 3Y5.15%
Revenue growth 5Y3.13%
Sales Q2Q%-7.49%

3.2 Future

ALWIT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.93% yearly.
Based on estimates for the next years, ALWIT will show a small growth in Revenue. The Revenue will grow by 2.04% on average per year.
EPS Next Y73.17%
EPS Next 2Y66.01%
EPS Next 3Y41.93%
EPS Next 5YN/A
Revenue Next Year10.41%
Revenue Next 2Y9.5%
Revenue Next 3Y2.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALWIT.PA Yearly Revenue VS EstimatesALWIT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
ALWIT.PA Yearly EPS VS EstimatesALWIT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

3

4. Valuation

4.1 Price/Earnings Ratio

ALWIT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALWIT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALWIT.PA Price Earnings VS Forward Price EarningsALWIT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALWIT indicates a somewhat cheap valuation: ALWIT is cheaper than 78.87% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALWIT indicates a rather cheap valuation: ALWIT is cheaper than 91.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.73
EV/EBITDA 5.13
ALWIT.PA Per share dataALWIT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

ALWIT's earnings are expected to grow with 41.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y66.01%
EPS Next 3Y41.93%

0

5. Dividend

5.1 Amount

ALWIT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WITBE.NET

EPA:ALWIT (9/26/2025, 7:00:00 PM)

1.7

-0.03 (-1.45%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)07-24 2025-07-24
Earnings (Next)N/A N/A
Inst Owners4.26%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.00M
Analysts86.67
Price Target3.69 (117.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-184.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF 4.73
P/OCF 1.64
P/B 1.38
P/tB N/A
EV/EBITDA 5.13
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.36
FCFY21.16%
OCF(TTM)1.03
OCFY60.84%
SpS5.4
BVpS1.23
TBVpS-0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.53%
ROE -22.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 101.76%
FCFM 6.66%
ROA(3y)-3.11%
ROA(5y)-3.02%
ROE(3y)-11.7%
ROE(5y)-16.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y3.08%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.51
Debt/EBITDA 1.49
Cap/Depr 72.48%
Cap/Sales 12.49%
Interest Coverage N/A
Cash Conversion 229.33%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.38
Altman-Z 0.98
F-Score6
WACC6.27%
ROIC/WACCN/A
Cap/Depr(3y)115.83%
Cap/Depr(5y)157.74%
Cap/Sales(3y)16.38%
Cap/Sales(5y)21.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.97%
EPS Next Y73.17%
EPS Next 2Y66.01%
EPS Next 3Y41.93%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.14%
Revenue growth 3Y5.15%
Revenue growth 5Y3.13%
Sales Q2Q%-7.49%
Revenue Next Year10.41%
Revenue Next 2Y9.5%
Revenue Next 3Y2.04%
Revenue Next 5YN/A
EBIT growth 1Y-191.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year500%
EBIT Next 3Y100.43%
EBIT Next 5YN/A
FCF growth 1Y130.93%
FCF growth 3YN/A
FCF growth 5Y42.3%
OCF growth 1Y682.1%
OCF growth 3Y-2.54%
OCF growth 5Y3.54%